๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum protein changes in women with earLY BREAST CANCER

โœ Scribed by Donna K. Thompson; James E. Haddow; Dwight E. Smith; Robert F. Ritchie


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
592 KB
Volume
48
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Serum immunoglobulins in women with brea
โœ Angelos E. Papatestas; John Bramis; Arthur H. Aufses Jr. ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 455 KB ๐Ÿ‘ 2 views

Serum immunoglobulins were determined in I20 women with breast cancer. A strong association between age at tumor diagnosis and serum IgA levels was noted. Relative hypoglobulinemia of IgA was associated with appearance of tumors early in life, and was more frequent among women with family history of

Changing trends in the decision-making p
โœ L. J. M. Caldon; S. J. Walters; M. W. R. Reed ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 113 KB

## Abstract ## Background Previous studies have indicated a predominance of passive decision-making styles among women with early-stage breast cancer in the UK offered a choice between breast-conserving surgery (BCS) and mastectomy. The aim of this study was to determine current decision-making st

Summary of aromatase inhibitor clinical
โœ Aman U. Buzdar; R. Charles Coombes; Paul E. Goss; Eric P. Winer ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 115 KB

Five years of adjuvant therapy with tamoxifen was considered the gold-standard treatment for postmenopausal women with estrogen receptor-positive breast cancer for many years. Data from a core group of clinical trials investigating the safety and efficacy of aromatase inhibitors (AIs) have challenge